A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer

S. F. Williams; J. D. Bitran; L. Kaminer; C. Westbrook; R. Jacobs; J. Ashenhurst; E. Robin; S. Purl; J. Beschorner; C. Schroeder

doi:10.1200/JCO.1987.5.2.260

A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer

S. F. Williams, J. D. Bitran, L. Kaminer, C. Westbrook, R. Jacobs, J. Ashenhurst, E. Robin, S. Purl, J. Beschorner, C. Schroeder

Medical Education

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Original language	English (US)
Pages (from-to)	260-265
Number of pages	6
Journal	Journal of Clinical Oncology
Volume	5
Issue number	2
DOIs	https://doi.org/10.1200/JCO.1987.5.2.260
State	Published - 1987

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.1987.5.2.260

Cite this

Williams, S. F., Bitran, J. D., Kaminer, L., Westbrook, C., Jacobs, R., Ashenhurst, J., Robin, E., Purl, S., Beschorner, J., & Schroeder, C. (1987). A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer. Journal of Clinical Oncology, 5(2), 260-265. https://doi.org/10.1200/JCO.1987.5.2.260

@article{b29e6532f6f547388e10bf686952872d,

title = "A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer",

author = "Williams, {S. F.} and Bitran, {J. D.} and L. Kaminer and C. Westbrook and R. Jacobs and J. Ashenhurst and E. Robin and S. Purl and J. Beschorner and C. Schroeder",

year = "1987",

doi = "10.1200/JCO.1987.5.2.260",

language = "English (US)",

volume = "5",

pages = "260--265",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "2",

}

Williams, SF, Bitran, JD, Kaminer, L, Westbrook, C, Jacobs, R, Ashenhurst, J, Robin, E, Purl, S, Beschorner, J & Schroeder, C 1987, 'A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer', Journal of Clinical Oncology, vol. 5, no. 2, pp. 260-265. https://doi.org/10.1200/JCO.1987.5.2.260

TY - JOUR

T1 - A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer

AU - Williams, S. F.

AU - Bitran, J. D.

AU - Kaminer, L.

AU - Westbrook, C.

AU - Jacobs, R.

AU - Ashenhurst, J.

AU - Robin, E.

AU - Purl, S.

AU - Beschorner, J.

AU - Schroeder, C.

PY - 1987

Y1 - 1987

UR - http://www.scopus.com/inward/record.url?scp=0023116395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023116395&partnerID=8YFLogxK

U2 - 10.1200/JCO.1987.5.2.260

DO - 10.1200/JCO.1987.5.2.260

M3 - Article

C2 - 3027271

AN - SCOPUS:0023116395

SN - 0732-183X

VL - 5

SP - 260

EP - 265

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 2

ER -

A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this